Literature DB >> 12752143

Multiple unilateral schwannomas: segmental neurofibromatosis type 2 or schwannomatosis?

M Leverkus1, L Kluwe, E-M Röll, G Becker, E-B Bröcker, V F Mautner, H Hamm.   

Abstract

Schwannomas are benign solitary tumours of the peripheral nerve sheaths. The occurrence of multiple schwannomas usually implies hereditary disease. The most frequent syndrome associated with multiple schwannomas is neurofibromatosis type 2 (NF2), which is defined by bilateral vestibular schwannomas. Schwannomatosis is a distinct disease characterized by multiple pathologically proven schwannomas in the absence of vestibular schwannomas. It is not currently known if the presence of multiple schwannomas confined to a limb may represent a mosaic form of NF2 or a distinct disease, because mutation analysis of these tumours is not routinely performed. We report a 31-year-old patient who presented with multiple slowly growing subcutaneous tumours on his left arm. His family history was negative for cutaneous tumours or central nervous system disease, and he did not have additional features of NF2. Magnetic resonance tomography and ophthalmological examination excluded vestibular schwannoma and eye stigmata of NF2. After resection of three tumours, histological analysis confirmed the diagnosis of benign schwannomas. Molecular genetic analysis by temperature gradient gel electrophoresis and microsatellite marker analysis demonstrated two distinct mutations of the NF2 gene (NF2) in two different schwannomas, with concomitant loss of heterozygosity in both tumours. In contrast, neither normal skin nor peripheral blood lymphocytes revealed mutations of NF2. The clinical and molecular genetic findings suggest that the diagnosis in our patient is schwannomatosis rather than segmental NF2 because the mutations found in different tumours were not identical. The possibility of a localized predisposition for the acquisition of NF2 mutations is discussed.

Entities:  

Mesh:

Year:  2003        PMID: 12752143     DOI: 10.1046/j.1365-2133.2003.05249.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  7 in total

1.  Ophthalmological manifestations in segmental neurofibromatosis type 1.

Authors:  M Ruggieri; P Pavone; A Polizzi; M Di Pietro; A Scuderi; A Gabriele; A Spalice; P Iannetti
Journal:  Br J Ophthalmol       Date:  2004-11       Impact factor: 4.638

2.  Superficial neurofibromas in the setting of schwannomatosis: nosologic implications.

Authors:  Fausto J Rodriguez; Bernd W Scheithauer; David George; Rajiv Midha; Mia MacCollin; Anat O Stemmer-Rachamimov
Journal:  Acta Neuropathol       Date:  2010-12-30       Impact factor: 17.088

3.  Double localization of a unilateral sporadic vestibular schwannoma.

Authors:  M Barbara; F Ronchetti; V Manni; S Monini
Journal:  Acta Otorhinolaryngol Ital       Date:  2008-02       Impact factor: 2.124

4.  Segmental neurofibromatosis type 2: discriminating two hit from four hit in a patient presenting multiple schwannomas confined to one limb.

Authors:  Elisabeth Castellanos; Isabel Bielsa; Cristina Carrato; Imma Rosas; Ares Solanes; Cristina Hostalot; Emilio Amilibia; José Prades; Francesc Roca-Ribas; Conxi Lázaro; Ignacio Blanco; Eduard Serra
Journal:  BMC Med Genomics       Date:  2015-01-24       Impact factor: 3.063

5.  Segmental schwannomatosis: characteristics in 12 patients.

Authors:  Abdulqader Alaidarous; Beatrice Parfait; Salah Ferkal; Joëlle Cohen; Pierre Wolkenstein; Juliette Mazereeuw-Hautier
Journal:  Orphanet J Rare Dis       Date:  2019-08-22       Impact factor: 4.123

6.  Multiple schwannomas with pseudoglandular element synchronously occurring under the tongue: A case report.

Authors:  Yong-Lin Chen; Deng-Qi He; Hai-Xia Yang; Yu Dou
Journal:  World J Clin Cases       Date:  2020-11-26       Impact factor: 1.337

7.  Mutations in LZTR1 add to the complex heterogeneity of schwannomatosis.

Authors:  Miriam J Smith; Bertand Isidor; Christian Beetz; Simon G Williams; Sanjeev S Bhaskar; Wilfrid Richer; James O'Sullivan; Beverly Anderson; Sarah B Daly; Jill E Urquhart; Alan Fryer; Cecilie F Rustad; Samantha J Mills; Amir Samii; Daniel du Plessis; Dorothy Halliday; Sebastien Barbarot; Franck Bourdeaut; William G Newman; D Gareth Evans
Journal:  Neurology       Date:  2014-12-05       Impact factor: 9.910

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.